Clinical Trial

A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated Triglycerides

Name: A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated Triglycerides — clinical trial record (NCT07766759)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics effects of a single dose of FXR0906 injection or placebo in Chinese healthy adult volunteers with or without TG increase.

Trial Details

NCT Number	NCT07766759
Lead Sponsor	Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.
Conditions	Healthy Adult Volunteers
Enrollment	24 participants
Start Date	2026-08-25
Primary Completion	2027-09-24 (estimated)
Study Completion	2027-12-20 (estimated)
Updated on ClinicalTrials.gov	2026-08-14